It has been reported that some somatic mutations, including ASXL1, BCOR, EZH2, SF3B1, SRSF2, STAG2, U2AF1, and ZRSR2 mutations are associated with an adverse prognosis of AML (12–14). Here, STAG2 is linked to acute myeloid leukemia.